Risk-adapted high-dose therapy including autologous and allogeneic stem cell transplantation for relapsed or aggressive non-Hodgkin's lymphoma - a phase II trial by the OSHO (East German Study Group for Haematology and Oncology)

Koenigsmann, M. and Kahl, C. and Freund, M. and Basara, N. and Niederwieser, D. and Sayer, H. and Theurich, S. and Christopeit, M. and Behre, G. and Mohren, M. and Franke, A. and Reichle, A. and Ganser, A. and Metzner, B. and Uharek, L. and Balleisen, L. and Hinke, A. and Hinke, R. and Casper, J. (2010) Risk-adapted high-dose therapy including autologous and allogeneic stem cell transplantation for relapsed or aggressive non-Hodgkin's lymphoma - a phase II trial by the OSHO (East German Study Group for Haematology and Oncology). BONE MARROW TRANSPLANTATION, 45. S253. ISSN 0268-3369

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 14 Apr 2020 10:04
Last Modified: 14 Apr 2020 10:04
URI: https://pred.uni-regensburg.de/id/eprint/25011

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.